Regeneron Pharmaceuticals Statistics

Total Valuation

LON:0R2M has a market cap or net worth of GBP 40.07 billion. The enterprise value is 29.01 billion.

Market Cap	40.07B
Enterprise Value	29.01B

Important Dates

The next estimated earnings date is Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	May 20, 2025

Share Statistics

Current Share Class	103.85M
Shares Outstanding	n/a
Shares Change (YoY)	+0.13%
Shares Change (QoQ)	-2.28%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	99.89M

Valuation Ratios

The trailing PE ratio is 11.50 and the forward PE ratio is 13.27.

PE Ratio	11.50
Forward PE	13.27
PS Ratio	3.67
PB Ratio	1.76
P/TBV Ratio	1.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.69, with an EV/FCF ratio of 12.09.

EV / Earnings	8.33
EV / Sales	2.78
EV / EBITDA	8.69
EV / EBIT	9.85
EV / FCF	12.09

Financial Position

The company has a current ratio of 4.93, with a Debt / Equity ratio of 0.09.

Current Ratio	4.93
Quick Ratio	3.90
Debt / Equity	0.09
Debt / EBITDA	0.60
Debt / FCF	0.87
Interest Coverage	83.17

Financial Efficiency

Return on equity (ROE) is 15.96% and return on invested capital (ROIC) is 8.04%.

Return on Equity (ROE)	15.96%
Return on Assets (ROA)	6.91%
Return on Invested Capital (ROIC)	8.04%
Return on Capital Employed (ROCE)	11.70%
Revenue Per Employee	719,237
Profits Per Employee	229,741
Employee Count	15,106
Asset Turnover	0.39
Inventory Turnover	2.44

Taxes

In the past 12 months, LON:0R2M has paid 375.31 million in taxes.

Income Tax	375.31M
Effective Tax Rate	9.73%

Stock Price Statistics

The stock price has decreased by -51.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-51.43%
50-Day Moving Average	556.97
200-Day Moving Average	744.92
Relative Strength Index (RSI)	40.39
Average Volume (20 Days)	8,509

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.00

Income Statement

In the last 12 months, LON:0R2M had revenue of GBP 10.90 billion and earned 3.48 billion in profits. Earnings per share was 30.52.

Revenue	10.90B
Gross Profit	5.32B
Operating Income	3.08B
Pretax Income	3.86B
Net Income	3.48B
EBITDA	3.46B
EBIT	3.08B
Earnings Per Share (EPS)	30.52

Full Income Statement

Balance Sheet

The company has 6.46 billion in cash and 2.09 billion in debt, giving a net cash position of 11.55 billion.

Cash & Cash Equivalents	6.46B
Total Debt	2.09B
Net Cash	11.55B
Net Cash Per Share	n/a
Equity (Book Value)	22.75B
Book Value Per Share	214.78
Working Capital	10.84B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.06 billion and capital expenditures -658.90 million, giving a free cash flow of 2.40 billion.

Operating Cash Flow	3.06B
Capital Expenditures	-658.90M
Free Cash Flow	2.40B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 48.80%, with operating and profit margins of 28.22% and 31.94%.

Gross Margin	48.80%
Operating Margin	28.22%
Pretax Margin	35.38%
Profit Margin	31.94%
EBITDA Margin	31.74%
EBIT Margin	28.22%
FCF Margin	22.02%

Dividends & Yields

This stock pays an annual dividend of 1.35, which amounts to a dividend yield of 0.26%.

Dividend Per Share	1.35
Dividend Yield	0.26%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	2.08%
Buyback Yield	-0.13%
Shareholder Yield	0.13%
Earnings Yield	8.69%
FCF Yield	5.99%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0R2M has an Altman Z-Score of 9.55 and a Piotroski F-Score of 3.

Altman Z-Score	9.55
Piotroski F-Score	3